Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
UiPath Inc (NYSE: PATH) closed the day trading at $10.82 down -1.90% from the previous closing price of $11.03. In other words, the price has decreased by -$1.90 from its previous closing price. On the day, 10.35 million shares were traded. PATH stock price reached its highest trading level at $11.125 during the session, while it also had its lowest trading level at $10.81.
Ratios:
For a better understanding of PATH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.50. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 2.83. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Macquarie Downgraded its Outperform to Neutral on June 03, 2024, whereas the target price for the stock was revised from $29 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 31 ’25 when Dines Daniel sold 9,988 shares for $12.00 per share. The transaction valued at 119,856 led to the insider holds 4,598,388 shares of the business.
Dines Daniel sold 45,000 shares of PATH for $542,776 on Jul 30 ’25. The CEO and Chairman now owns 4,608,376 shares after completing the transaction at $12.06 per share. On Jul 29 ’25, another insider, Dines Daniel, who serves as the CEO and Chairman of the company, sold 45,000 shares for $12.20 each. As a result, the insider received 548,788 and left with 4,653,376 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 5789122048 and an Enterprise Value of 4313039360. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.99 while its Price-to-Book (P/B) ratio in mrq is 3.41. Its current Enterprise Value per Revenue stands at 2.972 whereas that against EBITDA is -48.682.
Stock Price History:
The Beta on a monthly basis for PATH is 1.02, which has changed by -0.13990462 over the last 52 weeks, in comparison to a change of 0.15624678 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $15.93, while it has fallen to a 52-week low of $9.38. The 50-Day Moving Average of the stock is -9.57%, while the 200-Day Moving Average is calculated to be -13.77%.
Shares Statistics:
Over the past 3-months, PATH traded about 12.06M shares per day on average, while over the past 10 days, PATH traded about 10068430 shares per day. A total of 457.42M shares are outstanding, with a floating share count of 409.96M. Insiders hold about 23.38% of the company’s shares, while institutions hold 63.71% stake in the company. Shares short for PATH as of 1755216000 were 55137420 with a Short Ratio of 4.56, compared to 1752537600 on 58879215. Therefore, it implies a Short% of Shares Outstanding of 55137420 and a Short% of Float of 15.15.
Earnings Estimates
The company has 18.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0.12, with high estimates of $0.14 and low estimates of $0.07.
Analysts are recommending an EPS of between $0.61 and $0.44 for the fiscal current year, implying an average EPS of $0.55. EPS for the following year is $0.61, with 21.0 analysts recommending between $0.72 and $0.49.
Revenue Estimates
15 analysts predict $347.36M in revenue for the current quarter. It ranges from a high estimate of $348.59M to a low estimate of $345M. As of the current estimate, UiPath Inc’s year-ago sales were $316.25MFor the next quarter, 15 analysts are estimating revenue of $384.3M. There is a high estimate of $390M for the next quarter, whereas the lowest estimate is $373.4M.
A total of 18 analysts have provided revenue estimates for PATH’s current fiscal year. The highest revenue estimate was $1.55B, while the lowest revenue estimate was $1.55B, resulting in an average revenue estimate of $1.55B. In the same quarter a year ago, actual revenue was $1.43BBased on 20 analysts’ estimates, the company’s revenue will be $1.68B in the next fiscal year. The high estimate is $1.75B and the low estimate is $1.64B.
